Author  
Place of duty  
Title   양측성 유암 ( Bilateral Breast Carcinoma )
Publicationinfo   1991 Jan; 023(02): 436-443.
Key_word  
Full-Text  
Abstract   Increasing survival of patients with unilateral breast cancer due to earlier detection and prompt adequate treatment has placed emphasis on the second breast cancer. An incidence of synchronous second primary breast cancer, which is found significantly highly in first degree family history of breast cancer, is from 0.3 to 1.9 percent of breast cancer and that of metachronous second primary breast cancer is from 1 to 8.9 percent. The monclonal antibody DF-3 could be used as a biologic marker for synchronous bilateral breast cancer and synchronous estrogen receptor-positive tumors occurred significantly more frequently than expectide, suggesting that the development of the two tumors was influenced by a common mechanism. The presence of a synchronous breast cancer does not worsen the prognosis. Therefore, the treatment should not be different from the treatment of a unilateral breast cancer. On the contrary, it is reported that the relative hazard rate is signifintly higher for women with bilateral versus unilateral breast cancer. Recently authors experienced 5 cases of bilateral breast cancer which were treated with modified radical mastectomy or excision, and herein report with review of the literature.
저 자   박태하(Tae ha Park),박일영(Il Young Park),이재학(Jai Hak Lee)